Pharmacokinetics of a HER2 tyrosine kinase inhibitor CP-724,714 in patients with advanced malignant HER2 positive solid tumors: correlations with clinical characteristics and safety

✍ Scribed by Feng Guo; Stephen P. Letrent; Pamela N. Munster; Carolyn D. Britten; Karen Gelmon; Anthony W. Tolcher; Amarnath Sharma

• Publisher: Springer
• Year: 2007
• Tongue: English
• Weight: 382 KB
• Volume: 62
• Category: Article
• ISSN: 0344-5704
• DOI: 10.1007/s00280-007-0579-4